Article
Marked elevation in homocysteine and homocysteine sulfinic acid in the cerebrospinal fluid of lymphoma patients receiving intensive treatment with methotrexate.
International journal of clinical pharmacology and therapeutics - 1 Sept 2007
Becker A, Vezmar S, Linnebank M, Pels H, Bode U, Schlegel U, Jaehde U
Abstract excerpt
OBJECTIVE: Interference of methotrexate (MTX) with the metabolism of homocysteine may contribute to MTX neurotoxicity. In this pilot study we measured the concentration of homocysteine and related metabolites in the cerebrospinal fluid (CSF) of patients with primary central nervous system lymphoma undergoing intensive treatment with MTX. MATERIAL AND METHODS: CSF samples from lymphoma patients (n = 4) were drawn...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
